SAN DIEGO, CA / ACCESSWIRE / August 12, 2021 / Dermata Therapeutics, Inc. (“Dermata” or the “Company”) (NASDAQ:DRMA)(NASDAQ:DRMAW), a clinical-stage medical dermatology company focused on identifying, developing and commercializing innovative pharmaceutical…
Dermata Therapeutics, Inc. Announces Pricing of Upsized $18.0 Million Initial Public Offering
Share this article
More News


Q2 Sales Boost with Mixed Signals
August 16, 2026

Chainlink leads crypto gains with 5.2% rise ami…
August 16, 2026




Trump-Linked Crypto Trust Gets Bank Charter Nod
August 16, 2026